Title
Investing into domestic Manufacturing of Critical Medication and Vaccines for the Federal Government
Document Type
Report
Publication Date
1-2021
Journal
All Reports
Abstract
While the federal government has made numerous public announcements regarding their stimulus plan and promises to increase the domestic capacity to produce personal protective equipment, vaccines, and medical equipment, a critical aspect that has been neglected is the serious and ongoing shortages of critical medication. The government has promised to provide 4.28 billion to expand testing and contact tracing capacities, 7.5 billion towards PPE, and 500 million to the provinces and territories for “critical health care system needs and support for mitigation effects.” While these efforts as part of Trudeau’s Safe Restart Agreement are a good place to begin reducing the strain on the public healthcare system as a result of COVID-19, they neglect to highlight the importance of putting in place policies that ensure our healthcare system is able to function using only domestic resources.
Included in
Alternative and Complementary Medicine Commons, Health and Medical Administration Commons, Models and Methods Commons, Pharmaceutical Preparations Commons, Public Health Commons